The total number of records retrieved from this search are 4. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_200	Virus nameMeasles virus	Virus strainSchwarz and Edmonston MV strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMalignant pleural mesothelioma (MPM) cell line	Cell lineMeso 35	Concentration of cell lineDesnity of 5000 cells per well	In-vitro toxicityNA	AssayUptiBlue assay	In-vitro virus concentration0.1 MOI	In-vitro result52% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26539644
IDOV_201	Virus nameMeasles virus	Virus strainSchwarz and Edmonston MV strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMalignant pleural mesothelioma (MPM) cell line	Cell lineMeso 35	Concentration of cell lineDesnity of 5000 cells per well	In-vitro toxicityNA	AssayUptiBlue assay	In-vitro virus concentration1 MOI	In-vitro result25% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26539644
IDOV_202	Virus nameMeasles virus	Virus strainSchwarz and Edmonston MV strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMalignant pleural mesothelioma (MPM) cell line	Cell lineMeso 35	Concentration of cell lineDesnity of 5000 cells per well	In-vitro toxicityNA	AssayUptiBlue assay	In-vitro virus concentration10 MOI	In-vitro result10% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26539644
IDOV_262	Virus nameMeasles virus	Virus strainSchwarz and Edmonston MV strain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with anti-CD46 blocking mAb - 10μg/mL added 30 minutes before adding virus	Immune gene insertion in viral genomeNo	Source of cell lineNA	Origin of cell lineMalignant pleural mesothelioma (MPM) cell line	Cell lineMeso 35	Concentration of cell lineDesnity of 5000 cells per well	In-vitro toxicityNA	AssayUptiBlue assay	In-vitro virus concentration1 MOI	In-vitro result8% cancer cell viability on 9th day (cell viability as percentage compared to non-infected cells)	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID26539644